Gene therapy injection for knee osteoarthritis
Part of Bones, joints & muscles clinical trials.
This trial tests a new gene therapy injection for knee osteoarthritis. It aims to see if the treatment is safe and if it can help with knee pain and joint function in people with moderate knee osteoarthritis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years of age or older.
- You have knee pain and X-ray shows moderate knee osteoarthritis (grade 2 or 3).
- Your pain score is at least 3 out of 10 on a standard pain scale.
- You have not had any knee surgery on the study knee.
- You are not taking steroids or other strong immune-suppressing drugs.
- You do not have certain other types of arthritis or joint diseases.
- You are not pregnant, breastfeeding, or planning to become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether injected umbilical-cord stem cells can improve safety and reduce symptoms in people with moderate knee osteoarthritis. It focuses on people with significant knee pain who have not gotten enough relief from standard, non-procedure treatments.
This study tests an experimental injection called GNSC-001 given directly into the knee to see if it can reduce pain and improve knee function in people with knee osteoarthritis. If you join, you'll have one injection and then be followed for a year, and you'll need to stop your usual knee pain medicines during the study.
This trial tests a new knee injection called MAG200. It may reduce knee pain and make daily activities easier.
This early-phase study tests an injection of donor stem cells placed into the knee joint to help reduce symptoms of knee osteoarthritis. You may be eligible if you have long-lasting knee pain from mild-to-moderate arthritis and meet safety and imaging requirements.
This trial studies changes in joint fluid before and after a procedure called genicular artery embolization (GAE) for knee osteoarthritis. It aims to understand how the procedure works to reduce pain and improve knee function.
This trial tests a new treatment using donor stem cells injected into the knee for people with moderate knee osteoarthritis. It aims to see if these cells can reduce pain and improve function.
Hear when a new Osteoarthritis, Knee trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.